Pfizer to build 190m Biologics facility in Cork: related news

Pfizer to build 190m Biologics facility in Cork

The world's largest pharmaceutical company, Pfizer, is to invest €190m, with the support of IDA Ireland, in the establishment of a biologics facility at Shanbally, Co. Cork, the first time the company has placed a development of this kind outside of the US. The new research and development operation, which will create 100 high quality jobs over three years, will be built on a 30-acre site near Pfizer's existing plant in Ringaskiddy and is due for completion by the end of next year.

Friends meet, build social networks on online game sites: ONLINE GAME SITES SURGE IN POPULARITY AS PLACES TO BUILD SOCIAL NETWORKS

Friends meet, build social networks on online game sites: ONLINE GAME SITES SURGE IN POPULARITY AS PLACES TO BUILD SOCIAL NETWORKS

Pfizer, Ranbaxy settle Lipitor Patent dispute - Update2

(RTTNews) - Drug maker Pfizer Inc. (PFE) said Wednesday that it has agreed to settle substantially all patent litigations that involve its blockbuster cholesterol drug Lipitor with Indian generics manufacturer Ranbaxy Laboratories Ltd. (RBXLF.PK). The agreement would provide Pfizer with breathing space to develop newer drugs and would delay the entry of a generic version of Lipitor into the U.S. market by another twenty months, as Ranbaxy will have a license to sell generic versions of Lipitor and Caduet in the U.S. only effective November 30, 2011. Following the announcement, Pfizer's stock is currently up more than 2% in the regular trading session.

Gradle- A New Build System For Java and Groovy Projects Published

The new build system Gradle has been published by Hans Dockter Gradle. The system uses Groovy for its build scripts. The Gradle project is automated by its Gradle build. It runs on Teamcity and Bamboo and it is available with the following features:

Google to build technology facility at NASA research center

Google will develop a new technology facility at NASA's Ames Research Center in Mountain View, Calif, the parties announced.

Google to Build Tech Facility at Nasa Research Center

Google has has signed a 40-year lease for 42 acres to develop a new technology facility at Nasa's Ames Research Center in Mountain View, California. It has an option to extend the lease by five 10-year terms, stretching to a maximum of 90 years.

Google to Build Tech Facility at Nasa Research Center

Google has has signed a 40-year lease for 42 acres to develop a new technology facility at Nasa's Ames Research Center in Mountain View, California. It has an option to extend the lease by five 10-year terms, stretching to a maximum of 90 years.

Google to build tech facility at Nasa Research Center

Google has has signed a 40-year lease for 42 acres to develop a new technology facility at Nasa's Ames Research Center in Mountain View, California. It has an option to extend the lease by five 10-year terms, stretching to a maximum of 90 years.

Google to build tech facility at Nasa Research Center

Google has has signed a 40-year lease for 42 acres to develop a new technology facility at Nasa's Ames Research Center in Mountain View, California. It has an option to extend the lease by five 10-year terms, stretching to a maximum of 90 years.

Google to build technology facility at NASA Ames Research Center

Google Inc. will develop a new technology facility at NASA's Ames Research Center in Mountain View, Calif., the parties announced.

Parallels Desktop 5608 adds tools for Linux

Parallels Desktop Mac Build 5608, the latest build of the virtualization environment for Mac OS X, has been released. This build adds support for guest Parallels Tools for Linux in the latest Linux distributions (including Ubuntu 8). It also includes added support for running 3D graphics in your Windows VM on Mac OS X Leopard 10.5.3. If you're already using Parallels Desktop 3.0 for Mac, this new build is free download it via the Check for Updates option in the Parallels Desktop Help menu.

Build your own Linux server

Why build your own Linux server? It's a good question. The answer is simple: to save money. Instead of forking out for appliances such as the D-Link DFL-700, you can build one that does exactly what you want, and gain useful experience in the process.

Build a Web Chat Application using ASP.Net 3.5, LINQ and AJAX

We will build a very simple web chat application using the latest ASP.Net 3.5, LINQ, and AJAX from scratch just for fun and see how fast we can build it using LINQ. The web chat will: be accessible anywhere, be flicker-free, not use frames, not use application variables. More...

Pfizer says U.S. confirms patent on Lipitor

NEW YORK (Reuters) - The U.S. Patent and Trademark Office has notified Pfizer Inc it will confirm the patentability of claims on the drugmaker's basic patent for the company's blockbuster drug Lipitor, Pfizer said on Wednesday.

Pfizer says U.S. confirms patent on Lipitor

NEW YORK, April 30 (Reuters) - The U.S. Patent and Trademark Office has notified Pfizer Inc (PFE.N: Quote, Profile, Research) it will confirm the patentability of claims on the drugmaker's basic patent for the company's blockbuster drug Lipitor, Pfizer said on Wednesday.

Pfizer, Ranbaxy settle Lipitor patent dispute

said Wednesday that it has agreed to settle patent litigation with India-based generic drugmaker Ranbaxy Laboratories Ltd. Under terms of the settlement, Ranbaxy will obtain a license effective Nov. 30, 2011, to sell generic versions of Pfizer's cholesterol-lowering drug Lipitor and high blood-pressure and cholesterol treatment Caduet in the U.S. The agreement also allows Ranbaxy to sell generic versions of Lipitor on varying dates in Canada, Belgium, Netherlands, Germany, Sweden, Italy and Australia. Pfizer and Ranbaxy have resolved their Lipitor-related disputes in Malaysia, Brunei, Peru and Vietnam. However, the agreement does not cover ongoing litigation in Finland, Spain, Portugal, Denmark and Romania. End of Story

Pfizer settles U.S. Lipitor patent dispute with Ranbaxy

said Wednesday that it has agreed to settle patent litigation with India-based generic drugmaker Ranbaxy Laboratories Ltd. Under terms of the settlement, Ranbaxy will obtain a license effective Nov. 30, 2011, to sell generic versions of Pfizer's cholesterol-lowering drug Lipitor and high blood-pressure and cholesterol treatment Caduet in the U.S. The agreement also allows Ranbaxy to sell generic versions of Lipitor on varying dates in Canada, Belgium, Netherlands, Germany, Sweden, Italy and Australia. Pfizer and Ranbaxy have resolved their Lipitor-related disputes in Malaysia, Brunei, Peru and Vietnam. However, the agreement does not cover ongoing litigation in Finland, Spain, Portugal, Denmark and Romania. End of Story

How to Build a $150 Linux-based PC Through Online Deals and Coupons

If you've always wanted to build a computer from the ground up but never really had the time to find the necessary parts online, a coupon-centered blog called Coupon Codes Mall has done all the work for you. We think their choices lead to a pretty solid build, and all the coupon/sale links are current, but let's just say this straight-up: You should temper your expectations right now. It's a simple bare bones PC and it probably won't win any real tough benchmark contests. But it's hard to argue with useful and efficient cheapness.

How to Build a $150 Linux-Based PC Through Online Deals and Coupons

"If you've always wanted to build a computer from the ground up but never really had the time to find the necessary parts online, a coupon-centered blog called Coupon Codes Mall has done all the work for you. We think their choices lead to a pretty solid build, and all the coupon/sale links are current, but let's just say this straight-up: You should temper your expectations right now. It's a simple bare bones PC and it probably won't win any real tough benchmark contests. But it's hard to argue with useful and efficient cheapness.

Read draws the fire from Cork's wild celebrations

Chris Read defused an incendiary burst of three wickets in four balls from Dominic Cork to ensure that a potentially fascinating final day was gently laid to rest in the evening sunshine. Cork's preposterous celebrations when he bowled Samit Patel to reduce Nottinghamshire to 46 for three and give himself the chance of a second Old Trafford hat-trick confirmed that Lancashire could sniff a second championship win of the season.

Ranbaxy gets favorable ruling in Australia on Pfizer's Atorvastatin Patent

The Full Federal Court affirms the Australian Federal Court's Decision in Favor of Ranbaxy on Pfizer's Atorvastatin Patent on Appeal - Overall ruling mixed as court also upholds decision on another Pfizer patent.

Apple seeds iPhone build 5A331, OS X 10.6 build 10A96, Safari 4

To take full advantage of all features you need to login or register. Registration is completely free and takes only a few seconds.

Reader Question: Are tables easier?

"If you build your client a website and the deal is that they will take over the maintenance and all afterwards, wouldn’t it be best to build the site in tables? By this I mean using tables for the layout and CSS for positioning and styling (no nested tables). If your clients are not the tech-savvy, web-savvy clients and you are afraid that

tags will be confusing for them and they will not be able to work with them, would you build the site using tables?"

U.S. Patent and Trademark Office to Confirm Patentability of Lipitor Basic Patent

NEW YORK--(BUSINESS WIRE)--April 30, 2008 - Pfizer Inc announced today that the U.S. Patent & Trademark Office has issued a communication notifying the company that it will confirm the patentability of the claims of Pfizer's '893 basic patent for Lipitor. The Patent Office had conducted a re-examination of the '893 patent in response to a request by a law firm that represented the generic company Ranbaxy Laboratories Limited. The patent, which expires in March 2010 (including pediatric exclusivity), was previously the subject of litigation against Ranbaxy, in which Pfizer prevailed in both the trial and appeal courts.

Software Engineering for Ajax

Perhaps the greatest advantage of using the Google Web Toolkit to build Ajax applications is having the capability to leverage advanced software engineering. JavaScript was never meant to be used to build large applications. It lacks language features that assist in code organization and compile-time type checking. It also lacks mature tools for building large applications, such as automation, integrated development environments, debugging, and testing. This chapter looks at how to use the Java software engineering tools in GWT to build nontrivial high-quality Ajax applications.

Search took 0.12 seconds.